טוען...
Denosumab treatment is associated with the absence of circulating tumor cells in patients with breast cancer
BACKGROUND: The presence of circulating tumor cells (CTCs) in patients with breast cancer correlates to a bad prognosis. Yet, CTCs are detectable in only a minority of patients with progressive breast cancer, and factors that influence the abundance of CTCs remain elusive. METHODS: We conducted CTC...
שמור ב:
| הוצא לאור ב: | Breast Cancer Res |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6247738/ https://ncbi.nlm.nih.gov/pubmed/30458879 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-018-1067-y |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|